Vanguard Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3
Closed -$3.6K – 836
2026
Q2
$3.6K Buy
+3
New +$3.06K ﹤0.01% 490

Other funds holding LLY

Vanguard Advisers's LLY Position: Q3 2026 in Review

Vanguard Advisers sold out of Eli Lilly (LLY) in Q3 2026, closing a stake of 3 shares — an estimated $3.6K sold.

Vanguard Advisers first reported a position in LLY in Q2 2026 and held it in 1 quarter. The position peaked at $3.6K in Q2 2026. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Vanguard Advisers reported no remaining Eli Lilly position as of Q3 2026 after selling out during the quarter.
  • Vanguard Advisers sold 3 Eli Lilly shares in Q3 2026, an estimated $3.6K.
  • Vanguard Advisers first reported a position in Eli Lilly in Q2 2026 and held it in 1 quarter.
  • Vanguard Advisers's Eli Lilly position peaked at $3.6K in Q2 2026.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Vanguard Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.